Abstract:Telomere biology disorders (TBD) are caused by germline pathogenic variants in genes related to telomere maintenance and are characterized by critically short telomeres. In contrast to classical dyskeratosis congenita (DC), which is typically diagnosed in infancy, adult or late onset TBD frequently lack the typical DC triad and rather show variable organ manifestations and a cryptic disease course, thus complicating its diagnosis. Common variable immunodeficiency (CVID), on the other hand, is a primary antibody deficiency (PAD) syndrome. PADs are a heterogenous group of diseases characterized by hypogammaglobulinemia which occurs due to dysfunctional B lymphocytes and additional autoimmune and autoinflammatory complications. Genetic screening reveals a monogenic cause in a subset of CVID patients (15-35%). In our study, we screened the exomes of 491 CVID patients for the occurrence of TBD-related variants in 13 genes encoding for telomere/telomerase-associated proteins, which had previously been linked to the disease. We found 110/491 patients (22%) carrying 91 rare candidate variants in these 13 genes. Following the American College of Medical Genetics and Genomics (ACMG) guidelines, we classified two variants as benign, two as likely benign, 64 as variants of uncertain significance (VUS), four as likely pathogenic, and one heterozygous variant in an autosomal recessive disease gene as pathogenic. We performed telomere length measurement in 42 of the 110 patients with candidate variants and CVID. Two of these 42 patients showed significantly shorter telomeres compared to controls in both lymphocytes and granulocytes. Following the evaluation of the published literature and the patient's manifestations, we re-classified two VUS as likely pathogenic variants. Thus, 0.5-1% of all CVID patients in our study carry possibly pathogenic variants in telomere/telomerase-associated genes. Our data adds CVID to the broad clinical spectrum of cryptic adult-onset TBD. As the molecular diagnosis greatly impacts patient management and treatment strategies, we advise inclusion of all TBD-associated genes-despite their low prevalence-into the molecular screening of patients with antibody deficiencies.

Polygenic modifiers of expressivity in telomere biology disorders

Genetic modifiers and ascertainment drive variable expressivity of complex disorders

Different phenotypes with different endings—Telomere biology disorders and cancer predisposition with long telomeres

Statistical Dissection of the Genetic Determinants of Phenotypic Heterogeneity in Genes with Multiple Associated Rare Diseases

Complex trait associations in rare diseases and impacts on Mendelian variant interpretation

Genetics of human telomere biology disorders

Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes

Genetic modifiers of rare variants in monogenic developmental disorder loci

Polygenic basis and biomedical consequences of telomere length variation

The evolving genetic landscape of telomere biology disorder dyskeratosis congenita

Expanding the understanding of telomere biology disorder with reports from two families harboring variants in ZCCHC8 and TERC

Telomere biology disorders may manifest as common variable immunodeficiency (CVID)

Heterozygous RPA2 variant as a novel genetic cause of telomere biology disorders

A CRISPR base editing approach for the functional assessment of telomere biology disorder-related genes in human health and aging

Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Germline RTEL1 Variants in Telomere Biology Disorders

Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions

Mechanisms underlying phenotypic variation in neurogenetic disorders

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Investigating the role of common cis-regulatory variants in modifying penetrance of putatively damaging, inherited variants in severe neurodevelopmental disorders